Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Debt to Equity Over TimeNormalizing
Percentile Rank56
3Y CAGR+3.8%
5Y CAGR-5.7%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+3.8%/yr
Annual compound
5Y CAGR
-5.7%/yr
Recent acceleration
Percentile
P56
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
2 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | -25.6% |
| 2024 | 0.02 | -19.5% |
| 2023 | 0.03 | +86.9% |
| 2022 | 0.01 | -54.3% |
| 2021 | 0.03 | +46.0% |
| 2020 | 0.02 | +90.3% |
| 2019 | 0.01 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |